NORTH AMERICA MEDICAL ENZYMES MARKET FORECAST 2022-2030

 

TABLE OF CONTENTS

1.     RESEARCH SCOPE & METHODOLOGY   

1.1. STUDY OBJECTIVES     

1.2. SCOPE OF STUDY        

1.3. METHODOLOGY 

1.4. ASSUMPTIONS & LIMITATIONS        

2.     EXECUTIVE SUMMARY        

2.1. MARKET SIZE & ESTIMATES   

2.2. MARKET OVERVIEW     

3.     MARKET DYNAMICS  

3.1. KEY DRIVERS     

3.1.1. INCREASED INVESTMENT IN HEALTHCARE RESEARCH AND FACILITIES    

3.1.2. WIDENING APPLICATION IN MEDICAL INDUSTRY  

3.1.3. GROWING PREVALENCE OF CHRONIC DISEASES AND RISING AGING POPULATION         

3.2. KEY RESTRAINTS         

3.2.1. HANDLING AND SAFETY OF ENZYMES         

3.2.2. REGULATIONS FOR MEDICAL ENZYMES     

4.     KEY ANALYTICS        

4.1. IMPACT OF COVID-19 ON MEDICAL ENZYMES MARKET

4.2. KEY MARKET TRENDS  

4.3. PORTER’S FIVE FORCES ANALYSIS 

4.3.1. BUYERS POWER   

4.3.2. SUPPLIERS POWER        

4.3.3. SUBSTITUTION     

4.3.4. NEW ENTRANTS   

4.3.5. INDUSTRY RIVALRY        

4.4. OPPORTUNITY MATRIX

4.5. VENDOR LANDSCAPE   

4.6. VALUE CHAIN ANALYSIS         

4.6.1. RESEARCH AND DEVELOPMENT        

4.6.2. OPERATIONS        

4.6.3. OUTBOUND LOGISTICS  

4.7. KEY BUYING CRITERIA 

4.7.1. COST

4.7.2. QUALITY     

4.7.3. APPLICATION        

4.8. REGULATORY FRAMEWORK  

5.     MARKET BY TYPE      

5.1. HYDROLASE       

5.1.1. HYALURONIDASE  

5.1.2. LYSOZYMES

5.1.3. OTHER HYDROLASES ENZYMES        

5.2. THROMBOLYTIC 

5.2.1. STREPTOKINASE  

5.2.2. UROKINASE

5.2.3. OTHER THROMBOLYTIC ENZYMES    

5.3. DIGESTIVE ENZYME     

5.3.1. LACTASE     

5.3.2. L-ASPARAGINASE 

5.3.3. OTHER DIGESTIVE ENZYMES   

5.4. ENDONUCLEASE

5.4.1. BENZONASE

5.4.2. OTHER ENDONUCLEASES        

6.     MARKET BY APPLICATION  

6.1. DISEASE TREATMENT  

6.2. DIAGNOSTIC TOOLS    

6.3. BIOMEDICAL RESEARCH        

6.4. OTHER APPLICATIONS 

7.     GEOGRAPHICAL ANALYSIS 

7.1. NORTH AMERICA

7.1.1. MARKET SIZE & ESTIMATES     

7.1.2. KEY GROWTH ENABLERS         

7.1.3. KEY CHALLENGES

7.1.4. KEY PLAYERS       

7.1.5. COUNTRY ANALYSIS      

7.1.5.1. UNITED STATES      

7.1.5.2. CANADA        

8.     COMPETITIVE LANDSCAPE 

8.1. KEY STRATEGIC DEVELOPMENTS   

8.1.1. MERGERS & ACQUISITIONS     

8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS    

8.1.3. PARTNERSHIPS & AGREEMENTS       

8.1.4. BUSINESS EXPANSIONS & DIVESTITURES   

8.2. COMPANY PROFILES   

8.2.1. ADVANCED ENZYMES     

8.2.2. AMANO ENZYME   

8.2.3. BASF 

8.2.4. BBI SOLUTIONS    

8.2.5. BRAIN

8.2.6. CODEXIS     

8.2.7. CPC BIOTECH       

8.2.8. DSM  

8.2.9. DUPONT      

8.2.10. NOVOZYMES       

8.2.11. NOVUS      

8.2.12. ROCHE      

8.2.13. SANOFI     

8.2.14. SEKISUI     

8.2.15. THERMO FISHER SCIENTIFIC 

 

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - MEDICAL ENZYMES       

TABLE 2: MEDICAL APPLICATION OF VARIOUS ENZYMES        

TABLE 3: APPLICATIONS OF ENZYMES IN PHARMACEUTICALS INDUSTRY  

TABLE 4: REGULATORY FRAMEWORK        

TABLE 5: NORTH AMERICA MEDICAL ENZYMES MARKET, BY TYPE, HISTORICAL YEARS 2018-2021 (IN $ MILLION)      

TABLE 6: NORTH AMERICA MEDICAL ENZYMES MARKET, BY TYPE, FORECAST YEARS 2022-2030 (IN $ MILLION)        

TABLE 7: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, HISTORICAL YEARS 2018-2021 (IN $ MILLION) 

TABLE 8: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, FORECAST YEARS 2022-2030 (IN $ MILLION)   

TABLE 9: NORTH AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, HISTORICAL YEARS 2018-2021 (IN $ MILLION) 

TABLE 10: NORTH AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, FORECAST YEARS 2022-2030 (IN $ MILLION)     

TABLE 11: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, HISTORICAL YEARS 2018-2021 (IN $ MILLION) 

TABLE 12: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, FORECAST YEARS 2022-2030 (IN $ MILLION)             

TABLE 13: NORTH AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, HISTORICAL YEARS 2018-2021 (IN $ MILLION)   

TABLE 14: NORTH AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, FORECAST YEARS 2022-2030 (IN $ MILLION)               

TABLE 15: NORTH AMERICA MEDICAL ENZYMES MARKET, BY APPLICATION, HISTORICAL YEARS 2018-2021 (IN $ MILLION)      

TABLE 16: NORTH AMERICA MEDICAL ENZYMES MARKET, BY APPLICATION, FORECAST YEARS 2022-2030 (IN $ MILLION)                  

TABLE 17: NORTH AMERICA MEDICAL ENZYMES MARKET, BY COUNTRY, HISTORICAL YEARS 2018-2021 (IN $ MILLION)      

TABLE 18: NORTH AMERICA MEDICAL ENZYMES MARKET, BY COUNTRY, FORECAST YEARS 2022-2030 (IN $ MILLION)        

TABLE 19: LEADING PLAYERS OPERATING IN NORTH AMERICA MEDICAL ENZYMES MARKET                   

TABLE 20: LIST OF MERGERS & ACQUISITIONS    

TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS  

TABLE 22: LIST OF PARTNERSHIPS & AGREEMENTS      

TABLE 23: LIST OF BUSINESS EXPANSIONS & DIVESTITURES  

 

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS      

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS     

FIGURE 3: OPPORTUNITY MATRIX    

FIGURE 4: VENDOR LANDSCAPE       

FIGURE 5: VALUE CHAIN ANALYSIS   

FIGURE 6: KEY BUYING CRITERIA     

FIGURE 7: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021 

FIGURE 8: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2030 (IN $ MILLION)         

FIGURE 9: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY HYDROLASE ENZYME, IN 2021     

FIGURE 10: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2030 (IN $ MILLION)         

FIGURE 11: NORTH AMERICA MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2030 (IN $ MILLION)         

FIGURE 12: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2030 (IN $ MILLION)        

FIGURE 13: NORTH AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)    

FIGURE 14: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY THROMBOLYTIC ENZYME, IN 2021         

FIGURE 15: NORTH AMERICA MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2030 (IN $ MILLION)

FIGURE 16: NORTH AMERICA MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2030 (IN $ MILLION)         

FIGURE 17: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)    

FIGURE 18: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2030 (IN $ MILLION)    

FIGURE 19: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY DIGESTIVE ENZYME, IN 2021       

FIGURE 20: NORTH AMERICA MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2030 (IN $ MILLION)         

FIGURE 21: NORTH AMERICA MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2030 (IN $ MILLION)  

FIGURE 22: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2030 (IN $ MILLION)   

FIGURE 23: NORTH AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2030 (IN $ MILLION)

FIGURE 24: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY ENDONUCLEASE, IN 2021   

FIGURE 25: NORTH AMERICA MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2030 (IN $ MILLION)         

FIGURE 26: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2030 (IN $ MILLION)        

FIGURE 27: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021        

FIGURE 28: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2030 (IN $ MILLION)       

FIGURE 29: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2030 (IN $ MILLION)      

FIGURE 30: NORTH AMERICA MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2030 (IN $ MILLION)         

FIGURE 31: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)   

FIGURE 32: NORTH AMERICA MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021& 2030 (IN %)  

FIGURE 33: UNITED STATES MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)    

FIGURE 34: CANADA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)         

 

KEY FINDINGS

The North America medical enzymes market is predicted to progress with a CAGR of 6.34% during the forecasted period of 2022 to 2030. Some of the top drivers propelling the region’s market include the increasing number of chronic conditions, the rise in enzyme therapies, the growing investments in research and development, and the surging awareness about health as well as food and supplements.

 

Get more Insights into the North America Medical Enzymes Market:

https://inkwoodresearch.com/reports/north-america-medical-enzymes-market/

 

MARKET INSIGHTS

The North America medical enzymes market growth assessment constitutes the study of Canada and the United States. Technological developments, in addition to a significant manufacturing capacity as well as strong investments in enzyme advancements, are primarily ascribed to the market growth in Canada. As per a report issued by the World Health Organization (WHO), the two main causes of death in the country are cardiovascular disease and cancer. In this regard, according to the projections by the Canadian Cancer Society, in 2021, 118,200 men in Canada were estimated to be diagnosed with cancer, out of which 44,600 would die. Hence, medical enzymes utilized in the treatment of such diseases are anticipated to observe high demand in Canada.

On the other hand, with the rise in per capita income and improved medical awareness, the expenditure on healthcare is increasing. For instance, according to industry estimates, the gross domestic product per capita in Canada reached $48029.34 in 2021, compared to over $43814 in the previous year. As a result, these factors are set to influence the North America medical enzymes market growth over the forecasted years.

 

COMPETITIVE INSIGHTS

Key players operating in the market are DuPont, Novus, Codexis, etc.

 

Our report offerings include:

·       Explore key findings of the overall market

·       Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

·       Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

·       Market Segmentation cater to a thorough assessment of key segments with their market estimations

·       Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

·       Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

·       Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

·       Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

 

SEGMENTATION

1.     ADVANCED ENZYMES         

2.     AMANO ENZYME       

3.     BASF      

4.     BBI SOLUTIONS         

5.     BRAIN    

6.     CODEXIS         

7.     CPC BIOTECH  

8.     DSM       

9.     DUPONT

10. NOVOZYMES   

11. NOVUS  

12. ROCHE  

13. SANOFI  

14. SEKISUI 

15. THERMO FISHER SCIENTIFIC